TY - JOUR
T1 - Proteomic analysis of nasal mucus samples of healthy patients and patients with chronic rhinosinusitis
AU - Kao, Stephen Shih Teng
AU - Bassiouni, Ahmed
AU - Ramezanpour, Mahnaz
AU - Finnie, John
AU - Chegeni, Nusha
AU - Colella, Alex D.
AU - Chataway, Timothy K.
AU - Wormald, Peter John
AU - Vreugde, Sarah
AU - Psaltis, Alkis James
PY - 2021/1
Y1 - 2021/1
N2 - Background: Chronic rhinosinusitis (CRS) has a complex and multifactorial pathogenesis with a heterogeneous inflammatory profile. Proteomic analysis of nasal mucus may enable further understanding of protein abundances and biologic processes present in CRS and its endotypes compared with in healthy patients. Objective: Our aim was to determine differences in the nasal mucus proteome of healthy patients and patients with CRS. Methods: Nasal mucus was obtained from healthy patients, patients with CRS without nasal polyps (CRSsNP), and patients with CRS with nasal polyps (CRSwNP) before surgery. Gel electrophoresis was performed to fractionate the complex protein extracts before mass spectrometry analysis. Gene set enrichment analysis was performed on differentially expressed proteins. Results: A total of 33 patients were included in this study (12 healthy, 10 with CRSsNP, and 11 with CRSwNP). In all, 1142 proteins were identified in mucus samples from healthy patients, 761 in mucus samples from patients with CRSsNP, and 998 in mucus samples from patients with CRSwNP. Dysfunction in immunologic pathways, reduced cellular signaling, and increased cellular metabolism with associated tissue remodeling pathways were present in patients with CRS compared with in healthy patients. Conclusion: Significant downregulation of mucosal immunity and antioxidant pathways with increased tissue modeling processes may account for the clinical manifestations of CRS. Ultimately, the differing proteome and biologic processes provide further insight into CRS pathogenesis and its endotypes.
AB - Background: Chronic rhinosinusitis (CRS) has a complex and multifactorial pathogenesis with a heterogeneous inflammatory profile. Proteomic analysis of nasal mucus may enable further understanding of protein abundances and biologic processes present in CRS and its endotypes compared with in healthy patients. Objective: Our aim was to determine differences in the nasal mucus proteome of healthy patients and patients with CRS. Methods: Nasal mucus was obtained from healthy patients, patients with CRS without nasal polyps (CRSsNP), and patients with CRS with nasal polyps (CRSwNP) before surgery. Gel electrophoresis was performed to fractionate the complex protein extracts before mass spectrometry analysis. Gene set enrichment analysis was performed on differentially expressed proteins. Results: A total of 33 patients were included in this study (12 healthy, 10 with CRSsNP, and 11 with CRSwNP). In all, 1142 proteins were identified in mucus samples from healthy patients, 761 in mucus samples from patients with CRSsNP, and 998 in mucus samples from patients with CRSwNP. Dysfunction in immunologic pathways, reduced cellular signaling, and increased cellular metabolism with associated tissue remodeling pathways were present in patients with CRS compared with in healthy patients. Conclusion: Significant downregulation of mucosal immunity and antioxidant pathways with increased tissue modeling processes may account for the clinical manifestations of CRS. Ultimately, the differing proteome and biologic processes provide further insight into CRS pathogenesis and its endotypes.
KW - chronic rhinosinusitis
KW - endotypes
KW - Nasal mucus
KW - nasal polyps
KW - proteins
KW - proteomics
UR - http://www.scopus.com/inward/record.url?scp=85089868004&partnerID=8YFLogxK
U2 - 10.1016/j.jaci.2020.06.037
DO - 10.1016/j.jaci.2020.06.037
M3 - Article
C2 - 32750382
AN - SCOPUS:85089868004
SN - 0091-6749
VL - 147
SP - 168
EP - 178
JO - Journal of Allergy and Clinical Immunology
JF - Journal of Allergy and Clinical Immunology
IS - 1
ER -